| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36afc9a7a991fda247a0bd658f802da8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bedd17ebf078837f5a62aab18e5dd02b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d54b76d3c6c4d0f96cfa93b4ff3c4364
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7ae7a5a0ad0647aee592faf9cd0f63e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1efd5227b3edc17af04f4818a32a2e61 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D501-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-24 |
| filingDate |
2004-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc4f74e9c5e0e21e7a2ac128245d6a20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ffce3ec133d5720736f773303e3f9eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68babdcd224f14a1a1ffdbf3590aba15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1525b94beb427aa8f0e67c36583afd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03fd16c4c93877728f29c95e717d57d2 |
| publicationDate |
2005-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2005044824-A3 |
| titleOfInvention |
Processes for the preparation of highly pure 3-(2-substituted vinyl) cephalosporin |
| abstract |
The present invention relates to a process for preparation of highly pure amorphous and crystalline forms of cefditoren pivoxil and pharmaceutical compositions comprising highly pure amorphous and crystalline forms of cefditoren pivoxil. The present invention also relates to a method of treating infections using highly pure amorphous and crystalline forms of cefditoren pivoxil. The highly pure cefditoren pivoxil has a purity greater than 98.5% and contains less than 1.0% of the E-isomer impurity and less than 1 % of the Δ2isomer impurity. |
| priorityDate |
2003-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |